NATURAL HEALTH PRODUCT
LINDEN, LARGE-LEAF – TILIA PLATYPHYLLOS
This monograph is intended to serve as a guide to industry for the preparation of Product Licence
Applications (PLAs) and labels for natural health product market authorization. It is not intended
to be a comprehensive review of the medicinal ingredient.
Notes
Text in parentheses is additional optional information which can be included on the PLA and
product label at the applicant’s discretion.
The solidus (/) indicates that the terms and/or statements are synonymous. Either term or
statement may be selected by the applicant.
Date: July 18, 2017
Proper name(s):
Tilia platyphyllos Scop. (Tiliaceae) (USDA 2008)
Common name(s):
Linden (McGuffin et al. 2000; Wiersema and León 1999)
Large-leaf linden (McGuffin et al. 2000; Wiersema and León 1999)
Large-leaf lime (McGuffin et al. 2000; Wiersema and León 1999)
Tilia (McGuffin et al. 2000; Wiersema and León 1999)
Source material(s):
Flower (Bradley 1992; Felter and Lloyd 1983 [1898])
Route(s) of administration:
Oral
Dosage form(s):
This monograph is not intended to include foods or food-like dosage forms such as bars, chewing
gums or beverages.
Linden, Large-leaf Page 1 of 6
Dosage forms by age group:
Children 2 years: The acceptable dosage forms are limited to emulsion/suspension and
solution/drops (Giacoia et al. 2008; EMEA/CHMP 2006).
Children 3-5 years: The acceptable dosage forms are limited to chewables, emulsion/
suspension, powders and solution/drops (Giacoia et al. 2008; EMEA/CHMP 2006).
Children 6-12 years, Adolescents 13-17 years, and Adults ≥ 18 years: The acceptable
dosage forms include, but are not limited to capsules, chewables (e.g., gummies, tablets),
liquids, powders, strips or tablets.
Use(s) or Purpose(s):
Traditionally used in Herbal Medicine as a nervine to help relieve nervousness (Wichtl
2004; Hoffmann 2003; Bradley 1992) and restlessness (Bradley 1992; Felter and Lloyd
1983[1898]).
Traditionally used in Herbal Medicine to help relieve coughs and irritation of the throat in
colds and catarrh of the respiratory tract (Wichtl 2004; Blumenthal et al. 2000; Bradley
1992; Felter and Lloyd 1983 [1898]).
Dose(s):
Table 1: Dose information for linden flower presented as dose per day
Linden flower (g/day)
Subpopulation
Minimum Maximum
1
Children 2-4 y 0.2 2
Children and adolescents1 5-9 y 0.4 3
1
Adolescents 10-14 y 0.8 6
Adolescents and adults 1,2,3 ≥ 15 y 1.5 12
1
Children and adolescent doses were calculated as a fraction of the adult dose (JC 2008). The use of linden in
children and adolescents is supported by the following references: McIntyre 2005; Schilcher 1997; Bove 1996.
2
Adult dose supported by the following references: Hoffmann 2003; Blumenthal et al. 2000; Bradley 1992; Felter
and Lloyd 1983[1898].
3
Includes pregnant and breastfeeding women
See Appendix 1 for examples of appropriate dosage preparations, frequencies of use and
directions for use, according to cited references. The purpose of Appendix 1 is to provide
guidance to industry.
Duration of use:
No statement required.
Linden, Large-leaf Page 2 of 6
Risk information:
Caution(s) and warning(s):
Consult a health care practitioner if symptoms persist or worsen.
Contraindication(s):
No statement required.
Known adverse reaction(s):
Hypersensitivity and/or an allergy are known to occur; in which case, discontinue use (Mills and
Bone 2005; De Smet 1993).
Non-medicinal ingredients:
Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and
must meet the limitations outlined in the database.
Specifications:
The finished product specifications must be established in accordance with the requirements
described in the Natural and Non-prescription Health Products Directorate (NNHPD)
Quality of Natural Health Products Guide.
The medicinal ingredient must comply with the requirements outlined in the NHPID.
References cited:
BHP 1996: British Herbal Pharmacopoeia. Bournemouth (UK): British Herbal Medicine
Association; 1996.
Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E
Monographs. Boston (MA): Integrative Medicine Communications; 2000.
Bove M. An Encyclopedia of Natural Healing for Children and Infants. New Canaan (CT): Keats
Publishing, Incorporated; 1996.
Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on
Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association;
1992.
Linden, Large-leaf Page 3 of 6
De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs,
Volume 2. Berlin (DE): Springer-Verlag; 1993.
EMEA/CHMP 2006: European Medicines Agency: Pre-authorization Evaluation of Medicines
for Human Use. Committee for Medicinal Products for Human Use. Reflection Paper: Next link
will take you to another Web site Formulations of choice for the paediatric population. Adopted
September 2006. EMEA/CHMP/PEG/194810/2005. [Accessed on 2013 June 29].
Felter HW, Lloyd JU. King’s American Dispensatory, Volume 1, 18th edition. Sandy (OR):
Eclectic Medical Publications; 1983 [Reprint of 1898 original].
Giacoia GP, Taylor-Zapata P, Mattison D. Eunice Kennedy Shriver National Institute of Child
Health and Human Development Pediatric Formulation Initiative: selected reports from working
groups. Clinical Therapeutics 2008; 30(11):2097-2101.
Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
JC 2008: Justice Canada. Food and Drug Regulations. (C.01.021). Ottawa (ON): Justice Canada;
2008. [Accessed 2008-01-18]. Available from: http://laws.justice.gc.ca/en/F-27/C.R.C.-
c.870/text.html
McGuffin M, Kartesz JT, Leung AY, Tucker AO, editors. Herbs of Commerce, 2nd edition.
Silver Spring (MD): American Herbal Products Association; 2000.
McIntyre A. Herbal Treatment of Children - Western and Ayurvedic Perspectives. Toronto
(ON): Elsevier Limited; 2005.
Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill
Livingstone; 2005.
Schilcher H. Phytotherapy in Paediatrics: Handbook for Physicians and Pharmacists. Stuttgart
(D): Medpharm Scientific Publishers; 1997.
USDA 2007: United States Department of Agriculture, Agricultural Research Service, National
Genetic Resources Program. Germplasm Resources Information Network (GRIN). Tilia
platyphyllos Scop. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed
2008-01-23]. Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
USDA 2005: United States Department of Agriculture, Agricultural Research Service, National
Genetic Resources Program. Germplasm Resources Information Network (GRIN). Tilia x
europaea L. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed 2008-01-
23]. Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
USDA 2004: United States Department of Agriculture, Agricultural Research Service, National
Genetic Resources Program. Germplasm Resources Information Network (GRIN). Tilia cordata
Linden, Large-leaf Page 4 of 6
Mill. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed 2008-01-23].
Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a
Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.
Wiersema J, León B. World Economic Plants: A Standard Reference. Boca Raton (FL): CRC
Press LLC; 1999.
References reviewed:
Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The
Pharmaceutical Press; 2007.
Hutchens AR. Indian Herbology of North America. Boston (MA): Shambhala Publications, Inc.;
1991.
McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association’s
Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone;
2000.
Linden, Large-leaf Page 5 of 6
Appendix 1: Examples of appropriate dosage preparations, frequencies of use and directions for
use
Dried flower: 2-4 g, per day (Blumenthal et al. 2000)
Infusion:
1.8 g dried flower, 3 times per day (Hoffmann 2003)
1.8-2 g dried flower, 1-2 times per day (Blumenthal et al. 2000)
2-4 g dried flower, 3 times per day (Bradley 1992)
2-2.6 g (30 or 40 grains) dried flower, per day (Felter and Lloyd 1983
[1898])
Directions for use: Pour 150 ml to 473 ml (1 pint) of boiling water over
dried flowers and infuse for 10-15 minutes (Hoffmann 2003; Blumenthal
et al. 2000; Felter and Lloyd 1983 [1898]).
1.8 g = 1 tsp. (Wichtl 2004)
Fluidextract:
2 g dried equivalent, 1-2 times per day
(1:1, 2 ml) (Blumenthal et al. 2000)
2-4 g dried equivalent, 3 times per day
(1:1, 25% alcohol, 2-4 ml) (Bradley 1992)
Tincture:
0.5-1 g dried equivalent, 3 times per day
(1:5, 40% alcohol, 2.5-5 ml) (Hoffmann 2003)
2 g dried equivalent, 1-2 times per day
(1:5, 10 ml) (Blumenthal et al. 2000)
0.8-2 g dried equivalent, 3 times per day
(1:5, 25% alcohol, 4-10 ml) (Bradley 1992)
Linden, Large-leaf Page 6 of 6
